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A B S T R A C T
Background
An abdominal aortic aneurysm (AAA) is the pathological enlargement of the aorta and can develop in both men and women. Progressive
aneurysm enlargement can lead to rupture. The rupture of an AAA is frequently fatal and accounts for the death from haemorrhagic
shock of at least 45 people per 100,000 population. The outcome of people with ruptured AAA varies among countries and healthcare
systems, with mortality ranging from 53% to 90%. Definitive treatment for ruptured AAA includes open surgery or endovascular
repair. The management of haemorrhagic shock is crucial for the person’s outcome and aims to restore organ perfusion and systolic
blood pressure above 100 mmHg through immediate and aggressive fluid replacement. This rapid fluid replacement is known as
the normotensive resuscitation strategy. However, evidence suggests that infusing large volumes of cold fluid causes dilutional and
hypothermic coagulopathy. The association of these factors may exacerbate bleeding, resulting in a ’lethal triad’ of hypothermia,
acidaemia, and coagulopathy. An alternative to the normotensive resuscitation strategy is the controlled (permissive) hypotension
resuscitation strategy, with a target systolic blood pressure of 50 mmHg to 100 mmHg. The principle of controlled or hypotensive
resuscitation has been used in some management protocols for endovascular repair of ruptured AAA. It may be beneficial in preventing
blood loss by avoiding the clot disruption caused by the rapid increase in systolic blood pressure; avoiding dilution of clotting factors,
platelets and fibrinogen; and by avoiding the temperature decrease that inhibits enzyme activity involved in platelet and clotting factor
function. This is an update of a review first published in 2016.
Objectives
To compare the effects of controlled (permissive) hypotension resuscitation and normotensive resuscitation strategies for people with
ruptured AAA.
Search methods
The Cochrane Vascular Information Specialist searched the Specialised Register (August 2017), the Cochrane Register of Studies
(CENTRAL (2017, Issue 7)) and EMBASE (August 2017). The Cochrane Vascular Information Specialist also searched clinical trials
databases (August 2017) for details of ongoing or unpublished studies.
Selection criteria
We sought all published and unpublished randomised controlled trial (RCTs) that compared controlled hypotension and normotensive
resuscitation strategies for the management of shock in patients with ruptured abdominal aortic aneurysms.
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Data collection and analysis
Two review authors independently assessed identified studies for potential inclusion in the review. We used standard methodological
procedures in accordance with the Cochrane Handbook for Systematic Review of Interventions.
Main results
We identified no RCTs that met the inclusion criteria.
Authors’ conclusions
We found noRCTs that compared controlled hypotension and normotensive resuscitation strategies in themanagement of haemorrhagic
shock in patients with ruptured abdominal aortic aneurysm that assessed mortality, presence of coagulopathy, intensive care unit length
of stay, and the presence of myocardial infarct and renal failure. High quality studies that evaluate the best strategy for managing
haemorrhagic shock in ruptured abdominal aortic aneurysms are required.
P L A I N L A N G U A G E S U M M A R Y
Controlled hypotension versus normotensive resuscitation strategy for people with ruptured abdominal aortic aneurysm
Background
An abdominal aortic aneurysm (AAA) is a swelling (aneurysm) of the aorta, the main blood vessel that leads away from the heart and
through the abdomen to the rest of the body. It can develop in both men and women. A growing aneurysm can burst (rupture), which
leads to massive blood loss and shock. It is frequently fatal and accounts for the death of at least 45 people per 100,000 population.
One option to fix a ruptured AAA is to open the abdomen and place a tube graft in the aorta (open repair); the second approach is to
place a stent graft inside the aorta through the large artery in the thigh (femoral artery; endovascular repair).
This review focused on the initial management of bleeding and low blood pressure caused by the ruptured aneurysms, also known as
haemorrhagic shock. Patients are generally given intravenous (giving medicines or fluids through a needle or tube inserted into a vein)
saline solutions in the emergency room or surgery centre to restore circulatory volume.
Rapid fluid replacement immediately restores normal blood pressure. It is known as the normotensive resuscitation strategy and can
lead to an increase in bleeding because the clot can be removed and coagulation factors in the blood can be diluted. An alternative
approach is the controlled (permissive) hypotension resuscitation strategy. This strategy consists of fluid replacement, the use of drugs,
or both, to keep systolic blood pressure between 50 mmHg and 100 mmHg, until the aneurysms can be repaired with open surgery
or endovascular repair. This strategy might work because it does not introduce a large volume of cool saline solution and consequently
avoids the outcomes listed above.
Study characteristics and key results
We searched for evidence that directly compared strategies to manage haemorrhagic shock and to restore normal blood pressure initially,
and during surgery, in patients with ruptured AAA. Our searches up to August 2017, did not identify any randomised controlled
trials (clinical studies where people are randomly put into one of two or more treatment groups; one of which is the control group)
meeting our criteria. Studies are needed to help emergency physicians, vascular surgeons, and anaesthesiologists choose the best option
for treating haemorrhagic shock caused by ruptured abdominal aortic aneurysms.
Quality of the evidence
We found no randomised controlled trials that met our criteria.
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B A C K G R O U N D
Description of the condition
An abdominal aortic aneurysm (AAA) is the pathological enlarge-
ment of the aorta and candevelop in bothmen andwomen (Badger
2017). Prevalence rates vary according to age, gender, and geo-
graphical location (Moll 2011). According to randomised trials to
assess the benefits of screening and large epidemiological screen-
ing studies, it is most commonly seen in men over the age of 65
years, with total prevalence varying from4% to 8.9% (Moll 2011).
The NHS Abdominal Aortic Aneurysm Screening Programme re-
ported a prevalence of 1.5% during 2011 and 2012 of the men
invited for screening, a lower detection rate than expected (NHS
2013). Important risk factors for developing AAA are age, male
gender, and smoking. Progressive aneurysm enlargement can lead
to rupture, and the most important risk factors associated with
this complication, across several studies, include large aneurysm
diameter, female gender, smoking, hypertension, and AAA expan-
sion rate (Brown 1999; Hatakeyama 2001; Moll 2011; Powell
2008). The rupture of an AAA is frequently fatal, and accounts for
death from haemorrhagic shock of at least 45 people per 100,000
population (Anjum 2012). The outcome of people with ruptured
AAA (rAAA) varies among countries, with different results re-
ported for different healthcare systems;death ranges from 53% to
90% (Karthikesalingan 2014). Technical aspects, organisational
factors, and hospital-related factors all play an important role in
patient care (Karthikesalingan 2014).
Description of the intervention
Definitive treatment for rAAA includes open surgery or endovas-
cular repair (Badger 2017; Toomtong 2010). The management of
haemorrhagic shock in the pre- and intra-operative period is cru-
cial for the person’s outcome, and aims to restore organ perfusion
and systolic blood pressure above 100 mmHg by immediate and
aggressive fluid replacement. This rapid intravenous fluid replace-
ment (usually by crystalloid infusion, possibly by blood or volume
expanders) is known as the normotensive resuscitation strategy
(ATLS 2004; Roberts 2005). However, evidence suggests that in-
fusing large volumes of cold fluid causes dilutional coagulopathy
(loss or dilution of coagulation factors when blood is replaced with
fluids that do not contain coagulation factors) and hypothermic
coagulopathy (inhibition of enzyme activity involved in platelet
and clotting factor function caused by low temperatures). The as-
sociation of these factors may exacerbate bleeding, as the increased
blood flow, increased perfusion, and decreased blood viscosity may
result in clot disruption from vessel walls (Moll 2011; Roberts
2001), resulting in a ’lethal triad’ of hypothermia, acidaemia, and
coagulopathy (Morrison 2011; Roberts 2005). An alternative to
the normotensive resuscitation strategy is the controlled (permis-
sive) hypotension resuscitation strategy. This strategy has the target
systolic blood pressure of 50 mmHg to 100 mmHg. The principle
of controlled or hypotensive resuscitation has been used in some
management protocols for endovascular repair of rAAA (Mehta
2006; Park 2013).
How the intervention might work
In the management of people with rAAA, controlled hypoten-
sion resuscitation aims to replace sufficient fluid to maintain the
blood pressure between 50 mmHg and 100 mmHg during the
pre-operative and intra-operative period. The controlled hypoten-
sion strategy avoids large volumes of crystalloid replacement. It
may help to prevent blood loss by avoiding: the clot disruption
caused by a rapid increase in systolic blood pressure; the dilution
of clotting factors, platelets, and fibrinogen; and the temperature
decrease that inhibits enzyme activity involved in platelet and clot-
ting factor function. The principle of controlled hypotension is
widely adopted for people with trauma and has been applied for
people with rAAA with great success (Park 2013).
Why it is important to do this review
In 1991, Crawford showed a survival benefit with the adoption of
a controlled hypotension strategy with a target systolic blood pres-
sure of 50 mmHg to 70 mmHg in people with rAAA (Crawford
1991). There is evidence that a controlled hypotension strategy re-
duces blood requirements and severe coagulopathy in people with
trauma (Morrison 2011). However, one trial reported that the 30-
day mortality was higher among people with rAAA with recorded
systolic blood pressure less than 70 mmHg compared with people
with systolic blood pressure above 70 mmHg in the pre-operative
stage (IMPROVE 2013). People with rAAA are usually elderly and
more likely to have coronary and renal atherosclerotic disease, and
unlike younger people with trauma, are at greater risk of myocar-
dial infarction and renal insufficiency if submitted to low systolic
blood pressure levels.
The European Society for Vascular Surgery, in their 2011 guide-
lines on the management of abdominal aortic aneurysms, recom-
mended the hypotensive resuscitation strategy in case of abdomi-
nal aortic aneurysm rupture, suggesting the systolic blood pressure
should range between 50 mmHg and 100 mmHg depending on
the patient’s condition at admission. The European Society for
Vascular Surgery established this strategy as level 4, recommenda-
tion C (case series and poor quality cohort and case control stud-
ies) evidence, according to the levels of evidence from the Oxford
Centre For Evidence-Based Medicine (Moll 2011). In 2018, the
Society for Vascular Surgery published practice guidelines on the
care of patients with an abdominal aortic aneurysm. These prac-
tice guidelines recommend restricting aggressive volume infusion
3Controlled hypotension versus normotensive resuscitation strategy for people with ruptured abdominal aortic aneurysm (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
and implementing the permissive hypotension strategy with the
target systolic blood pressure between 70 mmHg and 90 mmHg
to limit excessive haemorrhage, for patients with rAAA. The level
of recommendation was described as strong with the quality of
the evidence graded as moderate (Chaikof 2018). According to
GRADE this can be interpreted as the benefits of the intervention
outweighs its risks or, alternatively, the risks outweigh its benefits,
but that further research is likely to have an important impact on
the estimate of effect (GRADE 2004).
In this review we wish to assess the available evidence of a possible
benefit of the controlled hypotension resuscitation strategy among
people with rAAA and to identify the systolic blood pressure range
that might be established to treat people with rAAA in the initial
management stage. This is an update of a review first published in
2016.
O B J E C T I V E S
To compare the effects of controlled (permissive) hypotension re-
suscitation and normotensive resuscitation strategies for people
with ruptured AAA.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We had planned to include randomised controlled trials (RCTs)
that compared a controlled hypotensive resuscitation strategy with
a normotensive resuscitation strategy in the treatment of people
with rAAA. We excluded non-randomised case series and data
from trials that had inferential data on the use of permissive hy-
potension in the treatment of people with rAAA.
Types of participants
We had planned to include all participants in whom a rAAA has
been diagnosed by ultrasonography, computerised tomography,
angiography, or magnetic resonance angiography. There had to
have been evidence of rupture on imaging, or objective acute symp-
toms of rupture of the aneurysm (abdominal or back pain in a
person with an aneurysm).
Types of interventions
Intervention: controlled hypotension or hypotensive resuscitation
strategy, which included all types of intravenous fluid replacement
or use of vasoactive drugs in pre- and intra-operative stages with
the target to achieve systolic blood pressure between 50 mmHg
and 100 mmHg in pre- and intra-operative stages.
Comparison: normotensive resuscitation strategy, which included
all types of intravenous fluid replacement or use of vasoactive drugs
with the target to achieve systolic blood pressure higher than 100
mmHg in pre- and intra-operative stages.
Types of outcome measures
Primary outcomes
• 30-day mortality (short term, due to haemorrhagic shock,
myocardial infarction, or renal insufficiency).
• Presence of coagulopathy (defined as International
Normalised Ratio (INR) greater than 1 to 3).
• Blood transfusion (measured by units or volume).
Secondary outcomes
• Intermediate mortality (30 days to one year).
• Long-term mortality (longer than one year).
• Total days of intensive care unit stay.
• Myocardial infarction.
• Renal failure.
Search methods for identification of studies
We had placed no restrictions on language or publication status.
Electronic searches
For this update the Cochrane Vascular Information Specialist
(CIS) searched the Specialised Register (14 August 2017), the
Cochrane Register of Studies (CRS, http://crso.cochrane.org/)
(CENTRAL (2017, Issue 7)) and EMBASE (8 August 2017).
In addition, the CIS searched the following trial databases (8 Au-
gust 2017) for details of ongoing and unpublished studies:
• ICTRP search portal (apps.who.int/trialsearch/);
• ClinicalTrials.gov ( clinicaltrials.gov/).
See Appendix 1 for details of the search strategies.
Searching other resources
We searched guidelines from the following societies from 2000 to
2015:
• The European Society for Vascular Surgery;
• The Society for Vascular Surgery;
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• The College of Emergency Medicine;
• The Royal College of Radiologists.
We had planned to supplement the above searches by checking the
references of included trials for further relevant studies. We had
also planned to contact the authors of included trials to request
any unpublished data.
Data collection and analysis
Selection of studies
Two review authors (DHM, DGC) independently evaluated the
trials to determine if they were appropriate to include.We resolved
disagreements by discussion within the review team.
Data extraction and management
We had intended that two review authors (DHM and DGC)
would independently extract the data. We had planned to resolve
disagreements by discussion within the review team.
Assessment of risk of bias in included studies
We had intended that three review authors (DHM, DGC, and
JBS) would independently assess the risk of bias using Cochrane’s
’Risk of bias’ tool, described in Section 8.5 of the Cochrane Hand-
book for Systematic Reviews of interventions (Higgins 2011).Wehad
planned to resolve disagreements by discussion within the review
team.
Measures of treatment effect
We had planned to use risk ratio (RR) for dichotomous data and
mean difference (MD) or standardised mean difference (SMD)
for continuous data with 95% confidence intervals (CI).
Unit of analysis issues
We had intended that the individual participant would be the unit
of analysis.
Dealing with missing data
We had intended to analyse only the available data and had
planned to contact the trial authors to request missing data. We
had planned to use intention-to-treat analysis.
Assessment of heterogeneity
We had intended to assess heterogeneity using the I² statistic. We
had planned to use these ranges to guide our interpretation of the
I² statistic: 0% to 30% indicated low heterogeneity, 30% to 60%
indicated moderate heterogeneity, 60% to 90% indicated substan-
tial heterogeneity, and 90% to 100% indicated considerable het-
erogeneity.
Assessment of reporting biases
We had intended to assess the presence of publication bias and
other reporting bias using funnel plots if sufficient studies (more
than 10) had been included in the meta-analysis (Higgins 2011).
Data synthesis
We had planned to synthesise the data using Review Manager 5
software (RevMan 2014). We had planned to use the fixed-effect
model to synthesise the data if there had been low to moderate
levels of heterogeneity. If there had been substantial heterogeneity,
we had planned to use a random-effects model. Had there been
considerable heterogeneity, we had planned to not undertake a
meta-analysis, but to describe the data in the text.
Subgroup analysis and investigation of heterogeneity
If sufficient data had been available, we had planned to perform
subgroup analyses for the following:
• Participant characteristics: age, gender, presence of
cardiopathy, renal dysfunction;
• Systolic blood pressure in pre-operative stage: 50 mmHg to
70 mmHg and 70 mmHg to 100 mmHg;
• Intervention: type of treatment - open surgery or
endovascular surgery.
Sensitivity analysis
We had planned to exclude studies with a high risk of bias from
meta-analysis to compare the overall treatment effect with and
without them.
Summary of findings
We had planned to prepare a ’Summary of findings’ table to pro-
vide the key information of the review. If trials are included in
future updates, the ’Summary of findings’ table will include infor-
mation about population at risk, interventions, and comparisons.
The table will contain a list of outcomes, the measure of bur-
den of these outcomes, absolute and relative magnitude of effect,
numbers of participants and studies addressing these outcomes,
overall quality of the body of evidence for each outcome, using
the GRADE (Grading of Recommendations Assessment, Devel-
opment and Evaluation) approach, and any relevant comments.
We intend to base this table on methods described in Chapter
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11 and Chapter 12 of the Cochrane Handbook for Systematic Re-
views of Interventions, and justify any departures from the standard
methods (GRADE 2004; Higgins 2011). The Types of outcome
measures section describes the review’s main outcomes to be in-
cluded in this table.
R E S U L T S
Description of studies
Results of the search
See Figure 1
Figure 1. Study flow diagram.
For this update we found no new RCTs that met the inclusion
criteria for this review.
From the titles and abstracts of the identified records, we classified
all 228 studies identified for this update as not relevant because
they were either not randomised controlled trials, or they did not
compare the specific types of interventions that we had planned
to assess.
Included studies
We found no studies that met the inclusion criteria.
Excluded studies
We excluded no studies from this review.
Risk of bias in included studies
It was not possible to assess methodological quality, as we found
no studies that met the inclusion criteria.
Effects of interventions
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We identified no RCTs that compared controlled hypotension
and normotensive resuscitation strategy for people with ruptured
abdominal aortic aneurysm.
D I S C U S S I O N
The concept of controlled hypotension in the management of
haemorrhagic shock has its basis in clinical trials of trauma patients
and animal model studies. The concept of permissive or controlled
hypotension is extrapolated for haemorrhagic shock caused by
ruptured abdominal aortic aneurysms by emergency physicians,
vascular and endovascular surgeons, and anaesthesiologists, but
there are no high-quality studies in this group of patients. There is
widespread use of permissive hypotension strategy as a basic prin-
ciple in the management of ruptured aneurysms, but the Euro-
pean Aortic Aneurysm Management practice guidelines list it as
a Level 4, Recomendation C (case series, poor quality cohort and
case control studies; Moll 2011).
Summary of main results
We found no RCTs comparing controlled hypotension versus nor-
motensive resuscitation strategies in patients with ruptured ab-
dominal aortic aneurysms.
Overall completeness and applicability of
evidence
We found no RCTs that evaluated the management of haemor-
rhagic shock with controlled hypotension versus normotensive re-
suscitation strategies in patients with ruptured abdominal aortic
aneurysms. For this update we identified 228 studies, which we
classified as not relevant because they were either not randomised
controlled trials or they did not compare the specific types of in-
terventions that we had planned to assess. We acknowledge that
designing and conducting an appropriate study for this topic is
difficult, considering the logistics and detailed monitoring that is
required for patients in the emergency room, during transport,
and in the operating theatre. Controlled hypotension is widely
used by vascular and endovascular surgeons, although there is no
evidence based on randomised controlled trials to support its use.
This fact reinforces the importance of this review, and serves as an
incentive for further investigation.
Quality of the evidence
We found no RCTs that were eligible for this review.
Potential biases in the review process
We identified no RCTs that were eligible for this review. The
Cochrane Vascular Information Specialist performed a compre-
hensive search of the literature and we selected studies according
to the Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011).
Agreements and disagreements with other
studies or reviews
In a systematic review published in 2014, which included several
experimental studies of trauma in animals, randomised trials of
trauma in humans and a prospective study on the treatment of
ruptured aneurysms in humans, Hamilton 2014 concluded that
the use of controlled hypotension in ruptured aortic aneurysms is
safe; in hospital systems, when diagnostic and logistics considera-
tions are optimised, permissive hypotension and delayed volume
resuscitation have apparent benefit, but the ideal target blood pres-
sure is not yet confirmed in elderly vascular patients. Hamilton
2014 referred toCrawford’s conclusion of an editorial published in
1991: “Crawford felt that no significant attempt should be made
for blood volume resuscitation until the time of operation. Systolic
blood pressure should be maintained at 50 mmHg to 70 mmHg
with small volumes of whole blood or crystalloid until the aorta
is clamped” (Hamilton 2014). Crawford based this conclusion on
the analysis of a case series, in which aggressive fluid replacement
was used in the pre-hospital resuscitation phase.
Van der Vliet 2007 published on the first series of patients who
received a controlled hypotension resuscitation strategy, which in-
cluded the use of pharmacological agents, and had a target systolic
blood pressure of 50 mmHg to 100 mmHg. They concluded that
controlled hypotension in associationwith endovascular treatment
was feasible in their tertiary referral centre.
Observations from the IMPROVE trial (EVAR versus open re-
pair for ruptured aortic aneurysms) on the haemodynamic status
of patients with ruptured abdominal aortic aneurysms, showed
a 30-day mortality rate of 51% among patients with a systolic
blood pressure lower than 70 mmHg and 34.1% in patients with
a recorded systolic blood pressure above 70 mmHg; systolic blood
pressure was directly related to the outcome in a linear fashion.
These findings suggest that maintaining systolic blood pressure
at less than 70 mmHg could be harmful to elderly patients, who
often experience atherosclerotic comorbidities, such as coronari-
opathy, renal disorders, and atherosclerosis (IMPROVE 2013).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The application of the controlled hypotension resuscitation strat-
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egy in patients with ruptured abdominal aortic aneurysms is
founded on basic principles and evidence from trauma studies and
animal models. Its use is currently accepted and is included in pro-
tocols of management of ruptured abdominal aortic aneurysms.
However, we found no RCTs that compared controlled hypoten-
sion versus normotensive resuscitation strategies in patients with
ruptured abdominal aortic aneurysms.
Implications for research
High-quality RCTs that compare controlled hypotensive resusci-
tation with normotensive resuscitation strategies in people with
ruptured abdominal aortic aneurysms are needed.
However, designing and conducting an appropriate study for this
topic is difficult. Possible study designs could: (a) assess shock
management strategies in patients with ruptured abdominal aortic
aneurysms who are scheduled for endovascular treatment or open
surgery and randomise patients to receive either controlled hy-
potensionor normotensive resuscitation, and (b) assess shockman-
agement strategies as part of RCTs designed to compare endovas-
cular versus open repair for ruptured abdominal aortic aneurysms.
In addition to the selected outcomes from this review, there are
other important outcomes that should be included in primary
studies investigating shock management in ruptured abdominal
aortic aneurysms, such as lower limb ischaemia, bowel ischaemia,
stroke respiratory failure, and quality of life. Platelets and fibrino-
gen doses could be assessed as an indicator of coagulopathy. A cost
analysis should also be considered as an outcome in future studies.
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A P P E N D I C E S
Appendix 1. Search strategies
Source Search strategy Hits retrieved
1. VASCULAR REGISTER IN CRSW AAA* AND INREGISTER 10
2. CENTRAL #1 MESH DESCRIPTOR Aortic
Aneurysm EXPLODE ALL TREES
#2 MESH DESCRIPTOR Aneurysm,
Ruptured EXPLODE ALL TREES
#3 ((aneurysm* near4 (abdom* or thora-
coabdom* or thoraco-abdom* or aort*))):
TI,AB,KY
#4 ((aort* near3 (ballon* or dilat* or bulg*)
)):TI,AB,KY
#5 AAA*:TI,AB,KY
#6 MESH DESCRIPTOR Aorta, Abdom-
inal EXPLODE ALL TREES
#7 #1 OR #2 OR #3 OR #4 OR #5 OR #6
#8 MESH DESCRIPTOR Fluid Therapy
EXPLODE ALL TREES
#9MESHDESCRIPTOR Infusions, Intra-
venous EXPLODE ALL TREES
#10 MESH DESCRIPTOR Lactic Acid
EXPLODE ALL TREES
#11 MESH DESCRIPTOR Glucose EX-
PLODE ALL TREES 15305
#12 MESH DESCRIPTOR Saline Solu-
tion, Hypertonic EXPLODE ALL TREES
#13 MESH DESCRIPTOR Mannitol EX-
PLODE ALL TREES
#14 MESH DESCRIPTOR Albumins EX-
PLODE ALL TREES
#15 MESH DESCRIPTOR Dextrans EX-
PLODE ALL TREES
#16 MESH DESCRIPTOR Isotonic Solu-
tions EXPLODE ALL TREES
#17 MESHDESCRIPTOR Plasma Substi-
tutes EXPLODE ALL TREES
#18 MESH DESCRIPTOR Osmotic Pres-
sure EXPLODE ALL TREES
#19 MESHDESCRIPTOR Hemodilution
EXPLODE ALL TREES
#20 MESH DESCRIPTOR Hemoglobins
EXPLODE ALL TREES
#21MESHDESCRIPTOR Blood Pressure
18
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(Continued)
EXPLODE ALL TREES
#22 MESH DESCRIPTOR Shock, Hem-
orrhagic EXPLODE ALL TREES
#23 MESH DESCRIPTOR Resuscitation
EXPLODE ALL TREES
#24 MESH DESCRIPTOR Hypotension
EXPLODE ALL TREES
#25 MESH DESCRIPTOR Hydroxyethyl
StarchDerivatives EXPLODE ALL TREES
#26 starch:TI,AB,KY
#27 hydroxyethyl*:TI,AB,KY
#28 ((haemoglobin or hemoglobin)):TI,
AB,KY 22443
#29 fluid:TI,AB,KY 17013
#30 ((saline or NaCl)):TI,AB,KY 21476
#31 dextran:TI,AB,KY
#32 ringer:TI,AB,KY
#33 lactate:TI,AB,KY
#34 glucose:TI,AB,KY
#35 gelatin:TI,AB,KY
#36 ((HES 130*)):TI,AB,KY
#37 voluven:TI,AB,KY
#38 albumin:TI,AB,KY
#39 mannitol:TI,AB,KY
#40 HBOC-201:TI,AB,KY
#41 ((crystalloid or colloid)):TI,AB,KY
#42 isovol*:TI,AB,KY
#43 normovol*:TI,AB,KY
#44 electrolyte:TI,AB,KY
#45 hypertonic:TI,AB,KY
#46 ((osmotic pressure)):TI,AB,KY
#47 ((volume loading)):TI,AB,KY
#48 ((volume expansion)):TI,AB,KY
#49 ((volume substitution)):TI,AB,KY
#50 ((haemodilution or hemodilution)):TI,
AB,KY
#51 resuscitation:TI,AB,KY
#52 hypotens*:TI,AB,KY
#53 normotensive :TI,AB,KY
#54 ((organ perfusion)):TI,AB,KY
#55 ((systolic blood pressure)):TI,AB,KY
#56 #8 OR #9 OR #10 OR #11 OR #12
OR #13 OR #14 OR #15 OR #16 OR #17
OR #18 OR #19 OR #20 OR #21 OR #22
OR #23 OR #24 OR #25 OR #26 OR #27
OR #28 OR #29 OR #30 OR #31 OR #32
OR #33 OR #34 OR #35 OR #36 OR #37
OR #38 OR #39 OR #40 OR #41 OR #42
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(Continued)
OR #43 OR #44 OR #45 OR #46 OR #47
OR #48 OR #49 OR #50 OR #51 OR #52
OR #53 OR #54 OR #55
#57 #7 AND #56
#58 (2016 OR 2017):YR
#59 #57 AND #58
3. Clinicaltrials.gov Condition/disease: abdominal aortic
aneurysm
31
4. ICTRP Search Portal abdominal aortic aneurysm OR Aneurysm,
Ruptured OR Ruptured Aneurysm AND
hypotens* OR resuscitat* OR Infus* OR
fluid* OR normotens*
1
5. EMBASE (via Ovid) 1 exp aorta aneurysm/
2 exp aneurysm rupture/
3 (aneurysm* adj4 (abdom* or thoracoab-
dom* or thoraco-abdom* or aort*)).mp.
[mp=title, abstract, heading word, drug
trade name, original title, device manufac-
turer, drugmanufacturer, device trade name,
keyword, floating subheading word]
4 (aort* adj3 (ballon* or dilat* or bulg*)).
mp. [mp=title, abstract, heading word, drug
trade name, original title, device manufac-
turer, drugmanufacturer, device trade name,
keyword, floating subheading word]
5 AAA*.mp. [mp=title, abstract, heading
word, drug trade name, original title, de-
vice manufacturer, drug manufacturer, de-
vice trade name, keyword, floating subhead-
ing word]
6 exp abdominal aorta/
7 1 or 2 or 3 or 4 or 5 or 6
8 exp fluid therapy/
9 exp intravenous drug administration/
10 exp lactic acid/
11 exp glucose/
12 *sodium chloride/
13 exp mannitol/
14 exp albuminoid/
15 exp dextran/
16 exp isotonic solution/
17 exp plasma substitute/
18 exp osmotic pressure/
19 exp hemodilution/
20 exp hemoglobin/
21 exp blood pressure/
180
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(Continued)
22 exp hemorrhagic shock/
23 exp fluid resuscitation/
24 exp hypotension/
25 exp hetastarch derivative/
26 exp starch/
27 (haemoglobin or hemoglobin).mp. [mp=
title, abstract, heading word, drug trade
name, original title, device manufacturer,
drug manufacturer, device trade name, key-
word, floating subheading word]
28 fluid.mp. [mp=title, abstract, heading
word, drug trade name, original title, de-
vice manufacturer, drug manufacturer, de-
vice trade name, keyword, floating subhead-
ing word]
29 (saline or NaCl).mp. [mp=title, abstract,
heading word, drug trade name, original
title, device manufacturer, drug manufac-
turer, device trade name, keyword, floating
subheading word]
30 dextran.mp. [mp=title, abstract, heading
word, drug trade name, original title, de-
vice manufacturer, drug manufacturer, de-
vice trade name, keyword, floating subhead-
ing word]
31 ringer.mp. [mp=title, abstract, heading
word, drug trade name, original title, de-
vice manufacturer, drug manufacturer, de-
vice trade name, keyword, floating subhead-
ing word]
32 lactate.mp. [mp=title, abstract, heading
word, drug trade name, original title, de-
vice manufacturer, drug manufacturer, de-
vice trade name, keyword, floating subhead-
ing word]
33 glucose.mp. [mp=title, abstract, heading
word, drug trade name, original title, de-
vice manufacturer, drug manufacturer, de-
vice trade name, keyword, floating subhead-
ing word]
34 gelatin.mp. [mp=title, abstract, heading
word, drug trade name, original title, de-
vice manufacturer, drug manufacturer, de-
vice trade name, keyword, floating subhead-
ing word]
35HES 130*.mp. [mp=title, abstract, head-
ingword, drug trade name, original title, de-
vice manufacturer, drug manufacturer, de-
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(Continued)
vice trade name, keyword, floating subhead-
ing word]
36 voluven.mp. [mp=title, abstract, heading
word, drug trade name, original title, de-
vice manufacturer, drug manufacturer, de-
vice trade name, keyword, floating subhead-
ing word]
37 albumin.mp. [mp=title, abstract, head-
ingword, drug trade name, original title, de-
vice manufacturer, drug manufacturer, de-
vice trade name, keyword, floating subhead-
ing word]
38 mannitol.mp. [mp=title, abstract, head-
ingword, drug trade name, original title, de-
vice manufacturer, drug manufacturer, de-
vice trade name, keyword, floating subhead-
ing word]
39 HBOC-201.mp. [mp=title, abstract,
heading word, drug trade name, original
title, device manufacturer, drug manufac-
turer, device trade name, keyword, floating
subheading word]
40 (crystalloid or colloid).mp. [mp=title, ab-
stract, heading word, drug trade name, orig-
inal title, device manufacturer, drug manu-
facturer, device trade name, keyword, float-
ing subheading word]
41 isovol*.mp. [mp=title, abstract, heading
word, drug trade name, original title, de-
vice manufacturer, drug manufacturer, de-
vice trade name, keyword, floating subhead-
ing word]
42 normovol*.mp. [mp=title, abstract,
heading word, drug trade name, original
title, device manufacturer, drug manufac-
turer, device trade name, keyword, floating
subheading word]
43 electrolyte.mp. [mp=title, abstract, head-
ingword, drug trade name, original title, de-
vice manufacturer, drug manufacturer, de-
vice trade name, keyword, floating subhead-
ing word]
44 hypertonic.mp. [mp=title, abstract,
heading word, drug trade name, original
title, device manufacturer, drug manufac-
turer, device trade name, keyword, floating
subheading word]
45 osmotic pressure.mp. [mp=title, abstract,
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(Continued)
heading word, drug trade name, original
title, device manufacturer, drug manufac-
turer, device trade name, keyword, floating
subheading word]
46 “volume loading”.mp. [mp=title, ab-
stract, heading word, drug trade name, orig-
inal title, device manufacturer, drug manu-
facturer, device trade name, keyword, float-
ing subheading word]
47 “volume expansion”.mp. [mp=title, ab-
stract, heading word, drug trade name, orig-
inal title, device manufacturer, drug manu-
facturer, device trade name, keyword, float-
ing subheading word]
48 “volume substitution”.mp. [mp=title, ab-
stract, heading word, drug trade name, orig-
inal title, device manufacturer, drug manu-
facturer, device trade name, keyword, float-
ing subheading word]
49 (haemodilution or hemodilution).mp.
[mp=title, abstract, heading word, drug
trade name, original title, device manufac-
turer, drugmanufacturer, device trade name,
keyword, floating subheading word]
50 resuscitation.mp. [mp=title, abstract,
heading word, drug trade name, original
title, device manufacturer, drug manufac-
turer, device trade name, keyword, floating
subheading word]
51 hypotens*.mp. [mp=title, abstract, head-
ingword, drug trade name, original title, de-
vice manufacturer, drug manufacturer, de-
vice trade name, keyword, floating subhead-
ing word]
52 normotensive.mp. [mp=title, abstract,
heading word, drug trade name, original
title, device manufacturer, drug manufac-
turer, device trade name, keyword, floating
subheading word]
53 “organ perfusion”.mp. [mp=title, ab-
stract, heading word, drug trade name, orig-
inal title, device manufacturer, drug manu-
facturer, device trade name, keyword, float-
ing subheading word]
54 “systolic blood pressure”.mp. [mp=title,
abstract, heading word, drug trade name,
original title, device manufacturer, drug
manufacturer, device trade name, keyword,
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(Continued)
floating subheading word]
55 8 or 9 or 10 or 11 or 12 or 13 or 14 or
15 or 16 or 17 or 18 or 19 or 20 or 21 or
22 or 23 or 24 or 25 or 26 or 27 or 28 or
29 or 30 or 31 or 32 or 33 or 34 or 35 or
36 or 37 or 38 or 39 or 40 or 41 or 42 or
43 or 44 or 45 or 46 or 47 or 48 or 49 or
50 or 51 or 52 or 53 or 54
56 7 and 55
57 randomized controlled trial/
58 exp controlled clinical trial/
59 random*.ab.
60 placebo.ab.
61 trial.ab.
62 groups.ab.
63 57 or 58 or 59 or 60 or 61 or 62
64 2017*.em.
65 56 and 63 and 64
TOTAL before de-duplication 240
TOTAL after de-duplication 228
WH A T ’ S N E W
Last assessed as up-to-date: 8 August 2017.
Date Event Description
23 May 2018 New citation required but conclusions have not changed Searches rerun, no new studies identified, Minor edits
made. Conclusions not changed
23 May 2018 New search has been performed Searches rerun, no new studies identified.
C O N T R I B U T I O N S O F A U T H O R S
Study selection: DHM and DGC.
Data extraction: DHM and DGC, with discussion by all three authors DHM, DGC and JBS.
Assessment of risk of bias of studies: DHM, DGC and JBS.
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